论文部分内容阅读
目的探讨支气管哮喘的临床特征及治疗措施。方法回顾分析我院70例患者的临床资料。结果本组临床控制53例,好转16例,无效转院1例,无死亡病例。住院天数1～42d,复发7例,其中3例住院2次,3例住院3次,1例住院4次。其中3例经BiPAP治疗,2h后PaO2明显升高,PaCO2明显下降(P<0.01),pH值明显升高(P<0.01)。结论支气管哮喘是多种因素引起的呼吸道慢性反应性疾病。BiPAP易于操作,使用方便,并可减少因气管插管造成黏膜损伤、院内感染,医疗费用也较低,易为患者接受,为重症支气管哮喘提供了一种有效的治疗手段。
Objective To investigate the clinical features and treatment of bronchial asthma. Methods The clinical data of 70 patients in our hospital were retrospectively analyzed. Results The clinical control in this group 53 cases, improved in 16 cases, invalid transfer in 1 case, no deaths. Days of hospitalization 1 ~ 42d, 7 cases of recurrence, of which 3 were hospitalized 2 times, 3 hospitalized 3 times, 1 hospitalized 4 times. Three of them were treated with BiPAP. After 2 hours PaO2 was significantly increased, PaCO2 was significantly decreased (P <0.01), pH value was significantly increased (P <0.01). Conclusion Bronchial asthma is a chronic respiratory disease caused by many factors. BiPAP easy to operate, easy to use, and can reduce tracheal intubation caused by mucosal injury, nosocomial infections, medical costs are also lower, easy for patients to accept, provides an effective treatment for severe bronchial asthma.